Khalid Mumtaz

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 8

Top Topics

Cardiovascular Disease

Kidney Transplantation

Glycemic Control

Top Venues

Alimentary pharmacology & therapeutics

Journal of clinical gastroenterology

Scientific reports

Journal of transplantation

This page only lists publications with an associated author ORCID identifier.

Publications

Mohamed I Elsaid, Na Li, Stephen A Firkins, Vinod K Rustgi, Electra D Paskett, Chathur Acharya, Rajender K Reddy, Chien Wei Chiang, Khalid Mumtaz
Impacts of glucagon-like peptide-1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction-associated steatotic liver disease cirrhosis and type 2 diabetes. Alimentary pharmacology & therapeutics 59 (9) (2024)
Mohamed I Elsaid, Na Li, Stephen A Firkins, Vinod K Rustgi, Electra D Paskett, Chathur Acharya, Rajender K Reddy, Chien Wei Chiang, Khalid Mumtaz
Impacts of glucagon-like peptide-1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction-associated steatotic liver disease cirrhosis and type 2 diabetes. Alimentary pharmacology & therapeutics 59 (9) (2024)
Mohamed I Elsaid, Na Li, Stephen A Firkins, Vinod K Rustgi, Electra D Paskett, Chathur Acharya, Rajender K Reddy, Chien Wei Chiang, Khalid Mumtaz
Impacts of glucagon-like peptide-1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction-associated steatotic liver disease cirrhosis and type 2 diabetes. Alimentary pharmacology & therapeutics 59 (9) (2024)
Mohamed I Elsaid, Na Li, Stephen A Firkins, Vinod K Rustgi, Electra D Paskett, Chathur Acharya, Rajender K Reddy, Chien Wei Chiang, Khalid Mumtaz
Impacts of glucagon-like peptide-1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction-associated steatotic liver disease cirrhosis and type 2 diabetes. Alimentary pharmacology & therapeutics (2024)
Mohamed I Elsaid, Na Li, Stephen A Firkins, Vinod K Rustgi, Electra D Paskett, Chathur Acharya, Rajender K Reddy, Chien Wei Chiang, Khalid Mumtaz
Impacts of glucagon-like peptide-1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction-associated steatotic liver disease cirrhosis and type 2 diabetes. Alimentary pharmacology & therapeutics 59 (9) (2024)
Andrew J Kruger, Marwan S Abougergi, Sajid Jalil, Lindsay A Sobotka, Michael R Wellner, Kyle M Porter, Lanla F Conteh, Sean G Kelly, Khalid Mumtaz
Outcomes of Nonvariceal Upper Gastrointestinal Bleeding in Patients With Cirrhosis: A National Analysis. Journal of clinical gastroenterology (2022)
Khalid Mumtaz, Jannel Lee-Allen, Kyle Porter, Sean Kelly, James Hanje, Lanla F Conteh, Anthony J Michaels, Ashraf El-Hinnawi, Ken Washburn, Sylvester M Black, Marwan S Abougergi
Thirty-day readmission rates, trends and its impact on liver transplantation recipients: a national analysis. Scientific reports 10 (1) (2020)
Eliza Wright Beal, Dmitry Tumin, Lanla F Conteh, A James Hanje, Anthony J Michaels, Don Hayes, Sylvester M Black, Khalid Mumtaz
Impact of Recipient and Donor Obesity Match on the Outcomes of Liver Transplantation: All Matches Are Not Perfect. Journal of transplantation 2016 (2016)